Pritelivir
Подписчиков: 0, рейтинг: 0
|
| |
| Names | |
|---|---|
|
Systematic IUPAC name
N-Methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-[4-(pyridin-2-yl)phenyl]acetamide | |
| Identifiers | |
|
3D model (JSmol)
|
|
| ChemSpider | |
|
PubChem CID
|
|
| UNII | |
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C18H18N4O3S2 | |
| Molar mass | 402.49 g·mol−1 |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Pritelivir (BAY 57-1293) is an antiviral helicase-primase complex inhibitor. Pritelivir is currently tested in phase 3 clinical trials as an antiviral for Herpes Simplex.
| Baltimore I |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hepatitis B (VII) | |||||||||||||||||||||
| Multiple/general |
|
||||||||||||||||||||
| |||||||||||||||||||||